Version 5.4
Bos taurus Protein: SLC18A1
Summary
InnateDB Protein IDBP-686170.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SLC18A1
Protein Name solute carrier family 18 (vesicular monoamine), member 1
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000043172
InnateDB Gene IDBG-634389 (SLC18A1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0015238 drug transmembrane transporter activity
GO:0022857 transmembrane transporter activity
Biological Process
GO:0006855 drug transmembrane transport
GO:0015893 drug transport
GO:0055085 transmembrane transport
Cellular Component
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR004734 Multidrug resistance protein
IPR005828 General substrate transporter
IPR011701 Major facilitator superfamily
IPR016196 Major facilitator superfamily domain, general substrate transporter
IPR020846 Major facilitator superfamily domain
PFAM PF00083
PF07690
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1MBH3
UniProt Splice Variant
Entrez Gene 617708
UniGene Bt.51028
RefSeq NP_001180100
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02023355 DAAA02023356 DAAA02023357 DAAA02023358 DAAA02023359
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca